Advertisement
Screener

TARSUS PHARMACEUTICALS, INC. (TARS) Net Margin

TARSUS PHARMACEUTICALS, INC. (TARS) Net Margin

  • 2026-06-30: Net Margin -10.67%.
  • 2026-03-31: Net Margin -4.30%.
  • 2025-12-31: Net Margin -5.52%.
  • 2025-09-30: Net Margin -10.60%.

Complete source-backed net margin history.

Available history
2021-03-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-10.67%
2026-03-31-4.30%
2025-12-31-5.52%
2025-09-30-10.60%
2025-06-30-19.81%
2025-03-31-32.07%
2024-12-31-34.80%
2024-09-30-48.67%
2024-06-30-81.57%
2024-03-31-129.39%
2023-12-31-320.45%
2023-09-30-2092.36%
2023-03-31-936.76%
2022-12-31-135.99%
2022-06-30-37.59%
2022-03-31-3754.73%
2021-12-31-4393.79%
2021-09-30-1265.89%
2021-06-3028.82%
2021-03-3131.04%

Annual Net Margin

DateNet Margin
2025-12-31-14.72%
2024-12-31-63.16%
2023-12-31-778.89%
2022-12-31-240.51%
2021-12-31-24.25%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Denali Therapeutics Inc. (DNLI)United States$3.274B-8.04
Relay Therapeutics, Inc. (RLAY)United States$3.884B-14.30
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Greenland Mines Ltd (GRML)United States$2.362B
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Adaptive Biotechnologies Corp (ADPT)United States$4.719B-53.43